NCT05948319

Brief Summary

the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
Last Updated

July 17, 2023

Status Verified

July 1, 2023

Enrollment Period

7 months

First QC Date

May 27, 2023

Last Update Submit

July 14, 2023

Conditions

Keywords

obesity,fetal epicardial thicknessmyocardial performance indexperinatal outcome

Outcome Measures

Primary Outcomes (3)

  • birth weight (gram)

    fetal outcome

    birth 1 week

  • stillbirth rate (%)

    fetal outcome

    birth 1 week

  • NICU admission

    fetal outcome

    6 months

Study Arms (2)

myocardial performance and epicard thickness in obese pregnant women

ACTIVE COMPARATOR

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Diagnostic Test: Doppler ultrasonography

obese pregnant

ACTIVE COMPARATOR

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Diagnostic Test: Doppler ultrasonography

Interventions

Doppler study was performed in all cases. perinatal outcomes were evaluated.

myocardial performance and epicard thickness in obese pregnant womenobese pregnant

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Obese pregnant women
  • normal-weight pregnant women
  • gestational week

You may not qualify if:

  • Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necmettin Erbakan University

Konya, 42140, Turkey (Türkiye)

Location

Related Publications (1)

  • Dogru S, Akkus F, Metin US, Acar A. Fetal Epicardial Fat Thickness in Obese Pregnant Women: Its Effect on Fetal Cardiac Function and Neonatal Outcomes. Z Geburtshilfe Neonatol. 2024 Oct;228(5):439-445. doi: 10.1055/a-2267-5478. Epub 2024 Mar 19.

MeSH Terms

Conditions

Fetus-in-FetuPregnancy ComplicationsObesity

Interventions

Ultrasonography, Doppler

Condition Hierarchy (Ancestors)

Twins, ConjoinedAbnormalities, Severe TeratoidCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • şükran DR doğru, md

    NECMETTİN ERBAKAN UNIVERCITY

    STUDY DIRECTOR
  • fatih dr akkuş, md

    NECMETTİN ERBAKAN UNIVERCITY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
obese and non obese pregnant women
Purpose
SCREENING
Intervention Model
SEQUENTIAL
Model Details: case control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical director

Study Record Dates

First Submitted

May 27, 2023

First Posted

July 17, 2023

Study Start

October 1, 2022

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

July 17, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

provided by the responsible researgher if requested

Shared Documents
CSR
Time Frame
2 MONTHS
Access Criteria
VİA MAİL ADDRESS

Locations